DALLAS, Sept. 1, 2009 (GLOBE NEWSWIRE) -- InvestorSoup.com.com announces an investment report featuring for BioNeutral Group Inc. (OTCBB:BONU). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The investment report on BioNeutral Group Inc. (OTCBB:BONU) should be of particular interest to biotechnology companies: NovaBay Pharmaceuticals Inc. (AMEX:NBY), Lipid Sciences Inc. (PinkSheets:LIPD), NeoPharm Inc. (PinkSheets:NEOL), and Quick-Med Technologies Inc. (OTCBB:QMDT).
It is available at: http://www.investorsoup.com/lp/BONU
Get our alerts BEFORE the rest of the market. Follow us on Twitter: www.twitter.com/investorsoup
BioNeutral Group Inc. (OTCBB:BONU) is a specialty chemical company engaged in commercializing chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms. BONU's formulations include natural and common ingredients, which are combined in various ways to create unique chemical formulations.
In the report, the analyst notes:
"BONU has the potential to access a growing market if it can successfully commercialize its formulations for mold elimination. The Chelsea Group, an Indoor Air Quality (IAQ) consulting and research firm, estimates that the size of the IAQ market caused by toxic mold is $2 billion to $3 billion annually, and Anthony Worthan, president and COO of IAQ consulting firm Air Quality Sciences, estimates that the IAQ market is growing at an annual rate of 25%.
"The Company commenced sales of its Ogiene-M(tm) formulation to Mr. Mold LLC (a New Jersey based mold remediation company) on May 26, 2009. The formulation is used in mold/mildew stain and order elimination, and rapidly breaks down into harmless substances making it an environmentally friendly solution. Thomas Re, founder and CEO of Mr. Mold LLC, said that Ogiene-M(tm) provided it with an edge over its competitors by providing a "green" solution to the potentially dangerous and costly problem of the spread of mold spores. BONU's CEO Stephen J. Browand said that the Company believed that others in the mold remediation industry would begin to recognize the tremendous benefits of BONU's unique formula."
To read the entire report visit: http://www.investorsoup.com/lp/BONU
See what investors say about these stocks at: http://www.stockhideout.com/
InvestorSoup.com is a small-cap research and investment commentary provider. InvestorSoup.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on InvestorSoup.com, please visit http://www.InvestorSoup.com
InvestorSoup.com Disclosure
InvestorSoup.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, InvestorSoup.com, for complete risks and disclosures.
CONTACT: InvestorSoup.com
Jeffrey Brown, Editor
(469)-252-3505
info@investorsoup.com
